Futura Medical PLC
31 March 2008
For immediate release 31 March 2008
Futura Medical Plc
('Futura' or 'the Company')
Board Changes
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative
products for the consumer healthcare market, is pleased to announce the
appointment as a Non-Executive Director of Lisa Arnold, who has extensive
experience of the investment and healthcare sectors.
Lisa, age 45, worked in the investment banking industry from 1984 to 2001,
holding senior positions in healthcare at Commerzbank and UBS. Since 2001, Lisa
has worked in non-executive and consultancy roles predominantly in the pensions,
healthcare and technology sectors.
Lisa is currently a Non-Executive Director of the UK's Medicines & Healthcare
Products Regulatory Agency (MHRA), where she chairs the Risk and Audit
Committee, and an adviser to the Allied Domecq Pension Funds and the Kraft UK
Pension Fund (Trustees).
On Lisa's appointment, Andrew Slater retires as a Non-Executive Director.
James Barder, Futura's Chief Executive, said: 'I am delighted to welcome Lisa to
Futura's Board as a Non-Executive Director. Her vast experience of the
healthcare and banking sectors will be of great value in the future development
of the Company. Also, on behalf of the Company, I would like to express our
gratitude to Andrew for his significant contribution to Futura during the past
five years and to wish him well for his retirement.'
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 685 670
mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk
Canaccord Adams Tel: +44 (0) 20 7050 6500
Ryan Gaffney / Adria Da Breo
For any media enquiries please contact:
Buchanan Communications Tel: +44 (0) 020 7466 5000
Mark Court / Rebecca Skye Dietrich / Catherine Breen
Director disclosures
Lisa Arnold currently holds no other company directorships or partnerships. Her
previous directorships or partnerships held in the five years preceding her
appointment at Futura Medical are as follows:
Previous Directorships Previous Partnerships
RAFT Trustees Limited GALA films
There are no other matters to be disclosed in relation to Schedule 2 paragraph
(g) and (i) of the AIM Rules.
Notes
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for
consumer healthcare. The Company is developing a portfolio of products and its
strategy is to license their manufacture and distribution to major
pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of
the London Stock Exchange.
www.futuramedical.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.